We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Tight Glucose Control Slashes Heart Risks

By HospiMedica staff writers
Posted on 22 Jun 2005
Frequent self-monitoring of blood glucose that guides the use of at least three insulin injections a day can lower the risk of heart events by about 50% in people with type 1 diabetes, according to the results of a study presented at the annual meeting of the American Diabetes Association in San Diego (ADA, CA, USA) in June 2005.

A multicenter study called the Diabetes Control and Complications Trial (DCCT) found in 1993 that intensive glucose control greatly reduces the eye, nerve, and kidney damage of type 1 diabetes as well as the risk of atherosclerosis. More...
Now researchers have found that what is more impressive is the long-lasting value of tight glucose control.

In the new results announced at the ADA meeting, involving 1,375 volunteers who continued to participate in the study, the intensely treated patients had less than half the number of cardiovascular events found in the conventionally treated group of patients. Cardiovascular events included heart attacks, stroke, angina, coronary artery disease requiring angioplasty, or coronary bypass surgery.

"The risk of heart disease is about 10 times higher in people with type 1 diabetes than in people without diabetes. It's now clear that high blood glucose levels contribute to the development of heart disease,” observed David Nathan, M.D., of Massachusetts General Hospital (Boston, USA), co-chair of the DCCT trial and the EDIC (Epidemiology of Diabetes Interventions and Complications) study follow-up.

"There is a strong and growing body of evidence that everyone with diabetes gains from strict blood glucose control,” noted Catherine Cowie, Ph.D., who oversees EDIC for the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, MD, USA), which funded the studies.





Related Links:
Mass. General Hospital
NIDDK

Gold Member
12-Channel ECG
CM1200B
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Pediatric Mask
Respire SOFT
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.